Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy BioPlus Acquisition stock (BIOS)

Buy BioPlus Acquisition stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

BioPlus Acquisition is a shell companies business based in the US. BioPlus Acquisition shares (BIOS) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $10.80 – the same closing value as a week prior.

What's in this guide?

  1. BIOS shares summary
  2. Compare share dealing platforms
  3. Is BIOS stock a buy or sell?
  4. Stock performance over time
  5. Can I short BIOS shares?
  6. Are BIOS shares over-valued?
  7. BioPlus Acquisition's financials
  8. Does BioPlus Acquisition pay a dividend?
  9. Other common questions

Our top picks for where to buy BioPlus Acquisition stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

Our pick for transfer bonus

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • Complimentary access to a financial planner and automated investing

How to buy BioPlus Acquisition stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BIOS. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy BioPlus Acquisition stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product USFST Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
Go to siteMore Info
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Go to siteMore Info
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Zero-commission stocks, ETFs and options, with no options per-contract fees. Plus, a no-advisory-fee robo-advisor and complimentary access to financial planners.
Go to siteMore Info
Robinhood
Finder Score: 4.5 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.5%
Get a free stock
Trade stocks, options, ETFs and crypto without commissions and on a user-friendly platform. Plus, a 1% IRA match and no options contract fees.
Go to siteMore Info
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

BioPlus Acquisition stock price (NASDAQ: BIOS)

Use our graph to track the performance of BIOS stocks over time.

BioPlus Acquisition shares at a glance

Information last updated 2024-06-30.
Latest market close$10.80
52-week range$0.00 - $0.00
50-day moving average $10.77
200-day moving average $10.55
Wall St. target price$20.00
PE ratio 51.4048
Dividend yield $0 (0%)
Earnings per share (TTM) $0.21

Is it a good time to buy BioPlus Acquisition stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

BioPlus Acquisition price performance over time

Historical closes compared with the close of $10.795 from 2023-10-13

1 week (2024-10-19) N/A
1 month (2024-09-26) N/A
3 months (2024-07-26) N/A
6 months (2024-04-26) N/A
1 year (2023-10-26) N/A
2 years (2022-10-28) 6.67%
3 years (2021-10-26) N/A
5 years (2019-10-30) 16.6

Is BioPlus Acquisition stock undervalued or overvalued?

Valuing BioPlus Acquisition stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of BioPlus Acquisition's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

BioPlus Acquisition's P/E ratio

BioPlus Acquisition's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, BioPlus Acquisition shares trade at around 51x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

BioPlus Acquisition financials

Gross profit TTM $0
Return on assets TTM -0.72%
Return on equity TTM 0%
Profit margin 0%
Book value $-0.86
Market Capitalization $209.1 million

TTM: trailing 12 months

BioPlus Acquisition share dividends

We're not expecting BioPlus Acquisition to pay a dividend over the next 12 months.

BioPlus Acquisition overview

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York. .

Frequently asked questions

What percentage of BioPlus Acquisition is owned by insiders or institutions?
Currently 48.687% of BioPlus Acquisition shares are held by insiders and 167.009% by institutions.
When does the fiscal year end for BioPlus Acquisition?
BioPlus Acquisition's fiscal year ends in December.
Where is BioPlus Acquisition based?
BioPlus Acquisition's address is: 260 Madison Avenue, New York, NY, United States, 10026
What is BioPlus Acquisition's ISIN number?
BioPlus Acquisition's international securities identification number is: KYG112171171
More resources on Finder

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site